XSpray Pharma shares up 13% in early trading
- Insider
- Blake Leitch
- Role
- Closely associated: Chief Executive Officer (VD)
- Company
- XSpray Pharma (XSPRAY)
- Transaction
- Buy
- Shares
- 50,000
- Amount
- SEK 475K
- Price per share
- SEK 9.51
- Trade date
- Sep 28, 2026
- Filed
- Sep 29, 2026, 1 day after the trade
- Source
- Finansinspektionen ↗
XSpray Pharma shares were up 13.3% at SEK 13.26 at 09:30 CET, against a previous close of SEK 11.70. The price is delayed by 15 to 20 minutes.
Blake Leitch, a closely associated person listed as Verkställande direktör (CEO), disclosed a purchase of 50,000 shares at SEK 9.51 on September 28, 2026. Against the first close after that purchase, SEK 9.95 on Sep 29, 2026, the share is up 33.3%.
Anders Bladh, a closely associated person listed as Styrelseledamot (board member), disclosed a purchase of 3,690 shares at SEK 10.50 on August 20, 2026. Two insiders have disclosed buying since Aug 20.
XSPRAY +13.3% on the day, delayed quote Nov 10
Today+13.3%At 09:30 CET, delayed
PriceSEK 13.26Previous close SEK 11.70
Disclosed buys2In the last 90 days
Since purchase+33.3%Blake Leitch, Sep 28